Companies: 10,795·Total market cap: $144.5T
NewcelX Ltd.

NewcelX Ltd.

NCELNASDAQHealthcare● Active
$3.09
$-0.15(-4.77%)
Market Cap$1388385
P/E Ratio—
52W High$30.8
52W Low$1.83
Overview

NewcelX Ltd. (NCEL) Revenue

Annual & quarterly revenue history · segment & region breakdown

NCEL · revenue · updated Jun 10, 2026

Core revenue metrics

NewcelX Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY —
Price / sales
—
mktCap ÷ TTM rev
Revenue per day
—
Est. TTM ÷ 365
Revenue / employee
$0K
11 employees
FY
—
FY
—
5Y CAGR
—
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · NewcelX Ltd. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

– · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
NCEL revenue by year · NCEL revenue history · NCEL annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income NewcelX Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

NewcelX Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from NewcelX Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.
Price historyFinancial statementsForecast

Frequently asked questions

NCEL revenue · 4 questions

NCEL's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

NCEL revenueNCEL annual revenuewhat is NCEL revenueNCEL TTM revenue

▸ Source: FMP · NewcelX Ltd. SEC filings · GAAP · NewcelX Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026